Limited studies on NDRG4 indicate that it may function as a tumor suppressor in multiple cancer types, including breast cancer (223), esophageal adenocarcinoma (224), colorectal cancer (225), and pancreatic cancer (103). Here, NDRG4 is linked to neoplasm.